Accredited Investors

Pre-NASDAQ Equity Investment:
Position for Stock Appreciation as the
$42B Pesticide Industry Transforms

We Beat Bayer and BASF in Scientific Testing. Now We're Planning Our NASDAQ Listing.

We've spent 10 years developing botanical pesticides validated by peer-reviewed studies that outperform chemical giants. Companies across all 50 states use our products, and we're planning a NASDAQ direct listing with reserved ticker MXRX.

Here's how accredited investors access pre-public equity before Wall Street gets access.

Here's What We've Actually Built:

Beat Bayer and BASF in peer-reviewed scientific testing – proven to outperform chemical giants in certain applications

$6.4M revenue in 4 years with zero debt – professional pest control companies across all 50 states use our products

Reserved NASDAQ ticker MXRX with clear path to public listing and liquidity

Regulatory tailwinds accelerating globally – Europe and Asia banning chemical pesticides, creating forced demand for alternatives

Expanding to 41+ countries with early discussions for government emergency response contracts

Buy restricted equity at private pricing before public market access opens up

Target IRR*

Equity Multiple*

Hold Period*

Distributions Once Stabilized*

Target Cash-on-Cash Returns*

Sponsor Assets Under Management

*Investment projections are not guaranteed.

This is a 506(c) investment offering open to accredited investors only with a minimum investment of $25,000 USD.

The following information is an investment summary provided to prospective investors and others. This information is not an offering to sell either a security or a solicitation to sell a security. At the request of a recipient, the Company will provide a private placement memorandum, subscription agreement and the Limited Liability Company Operating Agreement. The Managing Member in no way guarantees the projections contained herein. Real estate values, income, expenses and development costs are all affected by a multitude of forces outside the Managing Member’s control. This investment is illiquid and only those persons that are able and willing to risk their entire investment should participate. Please consult your attorney, CPA and/or professional financial advisor regarding the suitability of an investment by you.

Pre-NASDAQ Equity Investment: Position for Stock Appreciation as the $42B Pesticide Industry Transforms